PROZAC WEEKLY Drug Patent Profile
✉ Email this page to a colleague
When do Prozac Weekly patents expire, and what generic alternatives are available?
Prozac Weekly is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in PROZAC WEEKLY is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prozac Weekly
A generic version of PROZAC WEEKLY was approved as fluoxetine hydrochloride by APNAR PHARMA LP on August 2nd, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROZAC WEEKLY?
- What are the global sales for PROZAC WEEKLY?
- What is Average Wholesale Price for PROZAC WEEKLY?
Summary for PROZAC WEEKLY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 174 |
| Clinical Trials: | 110 |
| Patent Applications: | 5,914 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROZAC WEEKLY at DailyMed |
Recent Clinical Trials for PROZAC WEEKLY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Avy L. & Roberta L. Miller Foundation | Phase 2 |
| Stanford University | Phase 2 |
| Milton S. Hershey Medical Center | Early Phase 1 |
US Patents and Regulatory Information for PROZAC WEEKLY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | PROZAC WEEKLY | fluoxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235-001 | Feb 26, 2001 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROZAC WEEKLY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Lilly | PROZAC WEEKLY | fluoxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235-001 | Feb 26, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Lilly | PROZAC WEEKLY | fluoxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235-001 | Feb 26, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Lilly | PROZAC WEEKLY | fluoxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 021235-001 | Feb 26, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROZAC WEEKLY
See the table below for patents covering PROZAC WEEKLY around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| United Kingdom | 2325623 | Fluoxetine enteric pellets | ⤷ Sign Up |
| Lithuania | 98058 | ⤷ Sign Up | |
| Norway | 317743 | ⤷ Sign Up | |
| Indonesia | 20343 | ⤷ Sign Up | |
| South Africa | 9803173 | ⤷ Sign Up | |
| Turkey | 9800937 | ⤷ Sign Up | |
| Colombia | 4940407 | GRANULOS ENTERICOS DE FLUOXETINA | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
